Kymera Therapeutics

Kymera Appoints Industry Veteran Dr. Joanna Horobin to its Board of Directors

Cambridge, Mass. (April 23, 2018) – Kymera Therapeutics LLC, a biotechnology company pioneering targeted-protein degradation as a transformative new approach to creating breakthrough medicines for patients has announced that Joanna Horobin, M.B., Ch.B, Senior Vice President and Chief Medical